Vectors Research Management, LLC Pfizer Inc Transaction History

Vectors Research Management, LLC

$326 Million
Q2 2024

A detailed history of Vectors Research Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Vectors Research Management, LLC holds 12,178 shares of PFE stock, worth $361,199. This represents 0.1% of its overall portfolio holdings.

Number of Shares

12,178

Previous 12,235 0.47%

Holding current value

$361,199

Previous $340,000 0.29%

% of portfolio

0.1%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $1,439 - $1,687	-57 Reduced 0.47%	12,178 $341,000
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $5,178 - $5,946	200 Added 1.66%	12,235 $340,000
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $7,839 - $10,182	-300 Reduced 2.43%	12,035 $349,000
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $66,330 - $77,533	-2,067 Reduced 14.35%	12,335 $391,000
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $76,393 - $88,385	-2,115 Reduced 12.8%	14,402 $528,000
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $24,343 - $31,691	-618 Reduced 3.61%	16,517 $674,000
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $1,377 - $1,798	-33 Reduced 0.19%	17,135 $878,000
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $25,205 - $30,769	-576 Reduced 3.25%	17,168 $751,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $4,373 - $5,185	-94 Reduced 0.53%	17,744 $930,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $40,809 - $50,567	-892 Reduced 4.76%	17,838 $923,000
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $101,523 - $150,491	2,457 Added 15.1%	18,730 $1.11 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $45,137 - $57,983	-1,150 Reduced 6.6%	16,273 $700,000
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $5,027 - $5,695	140 Added 0.81%	17,423 $682,000
Q1 2021 May 18, 2021	BUY	$33.49 - $37.77 $87,777 - $98,995	2,621 Added 17.88%	17,283 $626,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $57,802 - $73,501	-1,727 Reduced 10.54%	14,662 $540,000
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $89,376 - $104,858	2,815 Added 20.74%	16,389 $498,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $34,336 - $41,655	1,140 Added 9.17%	13,574 $444,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $84,198 - $120,301	-3,115 Reduced 20.03%	12,434 $406,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $167,069 - $189,602	-5,075 Reduced 24.61%	15,549 $609,000
Q3 2019 Nov 15, 2019	SELL	$32.49 - $42.13 $31,482 - $40,823	-969 Reduced 4.49%	20,624 $741,000
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $73 - $83	2 Added 0.01%	21,593 $935,000
Q1 2019 Jul 15, 2019	BUY	$37.5 - $41.2 $223,162 - $245,181	5,951 Added 38.05%	21,591 $917,000
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $517,844 - $590,399	13,461 Added 617.76%	15,640 $683,000
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $75,110 - $91,103	2,179 New	2,179 $792,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Account

Vectors Research Management, LLC Pfizer Inc Transaction History